Rubin M, Mokyr M B
Department of Microbiology and Immunology, University of Illinois, Chicago 60680.
Cancer Immunol Immunother. 1993;36(1):37-44. doi: 10.1007/BF01789129.
We have shown previously that thymocytes from MOPC-315-tumor-bearing mice treated with low-dose melphalan (L-phenylalanine mustard) (L-PAM TuB mice) are superior to thymocytes from untreated MOPC-315-tumor-bearing mice or thymocytes from untreated normal mice or normal mice treated with low-dose melphalan in their ability to generate an antitumor cytotoxic response following 5-day in vitro stimulation with MOPC-315 tumor cells in the presence of a low concentration of recombinant interleukin-2 (rIL-2) [Mokyr MB, Bartik MM, Ahn M-C (1989) Cancer Res 49; 870]. Here we characterize the rIL-2 requirements for the generation of enhanced antitumor cytotoxicity by L-PAM TuB thymocytes relative to normal thymocytes upon in vitro stimulation with MOPC-315 tumor cells. Specifically, we show that delaying the addition of a low concentration of rIL-2 to 5-day in vitro stimulation cultures of thymocytes resulted in a progressive decline in the generation of antitumor cytotoxicity by both normal and L-PAM TuB thymocytes. However, even when rIL-2 was added on day 2 after culture initiation, thymocytes from L-PAM TuB mice generated a more potent antitumor cytotoxicity than did thymocytes from normal mice. In addition, when rIL-2 was added at the time of culture initiation, replacement of the conditioned medium with fresh medium lacking rIL-2 on day 3 of the 5-day in vitro stimulation culture period eliminated the ability of normal thymocytes, and reduced (but did not eliminate) the ability of L-PAM TuB thymocytes, to generate a significant level of antitumor cytotoxicity. A low concentration of fresh rIL-2 was sufficient to restore completely the generation of antitumor cytotoxicity by normal or L-PAM TuB thymocytes when added to the stimulation cultures immediately after the removal of the rIL-2-containing conditioned medium. The same low concentration of rIL-2 was also sufficient for restoring the generation of antitumor cytotoxicity by cultures of L-PAM TuB thymocytes, but not normal thymocytes, from which the rIL-2-containing medium was removed 1 day earlier. At the same time, conditioned medium from stimulation cultures of L-PAM TuB thymocytes was not superior to conditioned medium from stimulation cultures of normal thymocytes in supporting the generation of antitumor cytotoxicity by either normal or L-PAM TuB thymocytes.(ABSTRACT TRUNCATED AT 400 WORDS)
我们之前已经表明,用低剂量美法仑(L-苯丙氨酸氮芥)(L-PAM)处理的携带MOPC-315肿瘤的小鼠的胸腺细胞(L-PAM TuB小鼠),在低浓度重组白细胞介素-2(rIL-2)存在下,经MOPC-315肿瘤细胞体外刺激5天后,其产生抗肿瘤细胞毒性反应的能力优于未处理的携带MOPC-315肿瘤的小鼠的胸腺细胞、未处理的正常小鼠的胸腺细胞或用低剂量美法仑处理的正常小鼠的胸腺细胞[莫基尔MB,巴尔蒂克MM,安M-C(1989年)《癌症研究》49;870]。在此,我们描述了相对于正常胸腺细胞,L-PAM TuB胸腺细胞在经MOPC-315肿瘤细胞体外刺激时产生增强的抗肿瘤细胞毒性对rIL-2的需求。具体而言,我们发现,将低浓度rIL-2添加到胸腺细胞体外刺激培养5天的培养物中的时间推迟,会导致正常和L-PAM TuB胸腺细胞产生抗肿瘤细胞毒性的能力逐渐下降。然而,即使在培养开始后第2天添加rIL-2,L-PAM TuB小鼠的胸腺细胞产生的抗肿瘤细胞毒性也比正常小鼠的胸腺细胞更强。此外,在培养开始时添加rIL-2,在5天体外刺激培养期的第3天用不含rIL-2的新鲜培养基替换条件培养基,消除了正常胸腺细胞产生显著水平抗肿瘤细胞毒性的能力,并降低了(但未消除)L-PAM TuB胸腺细胞的这种能力。当在去除含rIL-2的条件培养基后立即将低浓度新鲜rIL-2添加到刺激培养物中时,足以完全恢复正常或L-PAM TuB胸腺细胞产生抗肿瘤细胞毒性的能力。同样低浓度的rIL-2也足以恢复提前1天去除含rIL-2培养基的L-PAM TuB胸腺细胞培养物产生抗肿瘤细胞毒性的能力,但不能恢复正常胸腺细胞培养物的这种能力。同时,L-PAM TuB胸腺细胞刺激培养物的条件培养基在支持正常或L-PAM TuB胸腺细胞产生抗肿瘤细胞毒性方面并不优于正常胸腺细胞刺激培养物的条件培养基。(摘要截短至400字)